MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

Cogent Biosciences Inc

Geschlossen

7.59 1.34

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

7.44

Max

7.71

Schlüsselkennzahlen

By Trading Economics

Einkommen

-4.1M

-72M

EPS

-0.525

Angestellte

205

EBITDA

-1.2M

-74M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+107.78% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

5. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

183M

817M

Vorheriger Eröffnungskurs

6.25

Vorheriger Schlusskurs

7.59

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

Cogent Biosciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

4. Juli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. Juli 2025, 15:57 UTC

Market Talk

Base Metal Prices Fall in Thin, Risk-off Trading -- Market Talk

4. Juli 2025, 15:49 UTC

Market Talk

Gold Futures Set to End Week Flat After Mixed Jobs Report -- Market Talk

4. Juli 2025, 15:49 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: Deal Will Have a Negative Impact of Approximately 30 Basis Points on the Fully-Loaded CET1 Ratio

4. Juli 2025, 15:49 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: Transaction Is Consistent With Targets in Terms of Return of Investment, Return on Tangible Equity

4. Juli 2025, 15:49 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole Received All Required Authorizations

4. Juli 2025, 15:48 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: CACEIS and Santander Are Maintaining Their Long-Term Partnership

4. Juli 2025, 15:47 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: Agreement Was Announced on Dec. 19

4. Juli 2025, 15:47 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole Now Controls 100% of the Share Capital of CACEIS

4. Juli 2025, 15:46 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole Completes Acquisition of Santander's 30.5% Stake in CACEIS

4. Juli 2025, 14:30 UTC

Akquisitionen, Fusionen, Übernahmen

Rocky Shore Closes Hemlo Area Claims Sale to Barrick Mining Unit for C$975,000 Cash

4. Juli 2025, 13:53 UTC

Market Talk

Polish Zloty Faces Hit From Prospect of Further Rate Cuts -- Market Talk

4. Juli 2025, 13:41 UTC

Market Talk

Japanese Yen Could Receive Boost From Increased Rate-Hike Bets -- Market Talk

4. Juli 2025, 13:41 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

4. Juli 2025, 13:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. Juli 2025, 12:37 UTC

Market Talk

Fund Manager Roundup: U.S. Treasurys in Focus Amid Rising Debt

4. Juli 2025, 12:37 UTC

Market Talk

Fund Manager Roundup: U.S. Treasurys in Focus -2-

4. Juli 2025, 12:30 UTC

Market Talk

Fund Manager Roundup: U.S. Tariff Deadline Key for Dollar Outlook, U.K. Fiscal Risks In Focus for Pound

4. Juli 2025, 12:15 UTC

Market Talk

Targeted Tariffs Would Likely Support Dollar -- Market Talk

4. Juli 2025, 12:13 UTC

Market Talk

Further Pause in Tariffs Would Have Unclear Impact on Dollar -- Market Talk

4. Juli 2025, 12:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. Juli 2025, 12:02 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

Peer-Vergleich

Kursveränderung

Cogent Biosciences Inc Prognose

Kursziel

By TipRanks

107.78% Vorteil

12-Monats-Prognose

Durchschnitt 15.75 USD  107.78%

Hoch 25 USD

Tief 7 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Cogent Biosciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

10 ratings

7

Buy

3

Halten

0

Sell

Technischer Score

By Trading Central

4.88 / 5.87Unterstützung & Widerstand

Kurzfristig

Bearish Evidence

Mittelfristig

Weak Bearish Evidence

Langfristig

Strong Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Cogent Biosciences Inc

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.